Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?51
Obesity and infertility: a double whammy40
Updates in thyroid healthcare delivery: advancing patient-centered care37
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome31
Advances in assessment and treatment of bone, mineral and parathyroid disorders30
Nutrition and thyroid disease24
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health24
Editorial introduction22
Editorial introduction22
Financial toxicity in thyroid cancer survivors21
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea21
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?20
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis20
Editorial introduction18
Recent advances in anaplastic thyroid cancer management18
Preventing type 1 diabetes development and preserving beta-cell function18
Interactions between antidiabetes medications and heart–brain axis17
Update on fracture risk assessment in osteoporosis15
An update on bone in diabetes15
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?14
Fibrous dysplasia in children and its management14
The use of anabolic agents in the treatment of osteoporosis: a clinical update14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia14
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency14
Assisted reproductive technology outcomes and management considerations for people with epilepsy13
Glucocorticoid withdrawal syndrome: what to expect and how to manage13
Epidemiologic changes in thyroid disease13
Precision medicine in diabetes care13
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries12
Editorial introductions12
The uncommon forms of congenital adrenal hyperplasia12
Editorial introductions12
Type 2 diabetes: a contemporary view from the Asian lens12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders11
Adrenal insufficiency and pregnancy10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation10
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease10
An update on investigation and management of renal bone disease10
A short history of saturated fat: the making and unmaking of a scientific consensus10
Editorial introductions10
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment9
Editorial introductions9
Legislation, medicine, and politics: care for gender diverse youth9
Time to cycle regularity and health risks9
Novel techniques for assessment of bone tissue material properties9
Editorial introductions9
Indications for testosterone therapy in men8
Type 2 diabetes mellitus and cognitive function: understanding the connections8
Multifactorial chylomicronemia syndrome8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective8
The future of triglyceride-regulating therapies and registries8
The interaction between gut microbiome and bone health8
0.10968017578125